Core Viewpoint - The data indicates significant outflows of capital from various stocks, highlighting potential concerns regarding investor sentiment and market stability [1] Group 1: Major Stocks with Capital Outflows - WuXi AppTec experienced a capital outflow of 367 million yuan [1] - Huadian Technology saw an outflow of 298 million yuan [1] - Lezhi Group had a capital outflow of 254 million yuan [1] - Inspur Information faced an outflow of 248 million yuan [1] - Yongding Holdings recorded an outflow of 245 million yuan [1] - Tianhua New Energy experienced a capital outflow of 211 million yuan [1] - Changxin Bochuang had an outflow of 198 million yuan [1] - Hainan Ruize saw an outflow of 197 million yuan [1] - Sanjiang Shopping recorded a capital outflow of 185 million yuan [1] - Yaowang Technology faced an outflow of 183 million yuan [1] - Tianji Holdings had a capital outflow of 182 million yuan [1] - CATL experienced an outflow of 159 million yuan [1] - BlueFocus Communication Group saw an outflow of 152 million yuan [1] - Industrial and Commercial Bank of China recorded a capital outflow of 151 million yuan [1] - China Film faced an outflow of 148 million yuan [1] - Vanke A experienced a capital outflow of 147 million yuan [1] - Guofeng New Materials saw an outflow of 142 million yuan [1] - Shiji Information recorded a capital outflow of 142 million yuan [1] - Meilixin faced an outflow of 135 million yuan [1] - Zhongwen Online experienced a capital outflow of 134 million yuan [1]

Core Viewpoint - The Hang Seng Index opened with a slight increase of 0.07%, while the Hang Seng Tech Index experienced a minor decline of 0.1% [1] Company Performance - WuXi AppTec saw a decline of over 3% [1] - NIO experienced a drop of more than 2% [1] - Zijin Mining reported an increase of over 2% [1]

Core Viewpoint - The U.S. Department of Defense has suggested including companies like Alibaba, Baidu, and BYD on a list of firms that assist the Chinese military, indicating potential scrutiny and implications for U.S. investors [1] Group 1: Companies Mentioned - Alibaba, Baidu, and BYD are identified as companies that may be involved with the Chinese military and are recommended for inclusion in the 1260H list [1] - Other companies mentioned include NewEase, Huahong Semiconductor, SUTENG, WuXi AppTec, and Zhongji Xuchuang, which also meet the criteria for the 1260H list [1] Group 2: Regulatory Context - The 1260H list aims to identify companies operating in the U.S. that are associated with the Chinese military, serving as a warning for U.S. investors despite lacking direct legal enforcement [1] - The letter from Deputy Secretary Stephen Feinberg to congressional leaders highlights the growing concern regarding U.S. investments in companies linked to the Chinese military [1]

Short Selling Ratios - Geely Automobile-R (80175), Kuaishou-WR (81024), and JD Health-R (86618) have the highest short selling ratios at 100.00% each [1][2] - China Ping An-R (82318) has a short selling ratio of 89.61%, while SenseTime-WR (80020) and China Resources Beer-R (80291) follow with 89.27% and 75.13% respectively [2] Short Selling Amounts - Alibaba-SW (09988) leads in short selling amount with 3.768 billion, followed by Meituan-W (03690) at 2.272 billion and Xiaomi Group-W (01810) at 1.584 billion [3] - Tencent Holdings (00700) and AIA Group (01299) also feature in the top five with short selling amounts of 1.242 billion and 0.582 billion respectively [3] Short Selling Deviation Values - China Ping An-R (82318) has the highest deviation value at 64.42%, indicating significant divergence from its historical short selling average [4] - Geely Automobile-R (80175) and Kuaishou-WR (81024) follow with deviation values of 56.33% and 40.21% respectively [4] - Baidu Group-SWR (89888) also shows a notable deviation value of 36.29% [4]

格隆汇11月27日丨根据联交所最新权益披露资料显示，2025年11月21日，药明康德(02359.HK)获JPMorgan Chase & Co.以每股均价102.4881港元增持好仓 73.65万股，涉资约7548.34万港元。 增持后，JPMorgan Chase & Co.最新持好仓数目为25,720,236股，持好仓比例由4.89%上升至5.03%。 | 股份代號: | 02359 | | --- | --- | | 上市法國名稱: | 無錫藥明康德新藥開發股份有限公司 - H股 | | 日期 (日 / 月 / 年): | 27/10/2025 - 27/11/2025 | | 麦格序號 | 大股東/董事/最高行政人員名稱 作出披露的 買入 / 賣出或涉及的股 每股的平均價 | | | | 持有權益的股份數目 | 佔已發行的 有關事 | | --- | --- | --- | --- | --- | --- | --- | | | 份數目 | 原因 | | | | (請參閱上述 * 註解) 有投票權股 (日 / 月 | | | | | | | | 份自分比 | | | | | | | | 96 1 | ...

（文章来源：证券日报） 证券日报网讯 11月26日晚间，药明康德发布公告称，2025年11月26日，公司收到信息披露义务人发出 的通知，获知其于2025年11月20日至2025年11月25日通过集中竞价方式合计减持公司股份11，827，898 股，占本公告日公司总股本的0.40%。信息披露义务人及与实际控制人签署投票委托书的股东合计持有 公司股份数从547，539，294股减少至535，711，396股，持股比例从18.35%减少至17.95%，权益变动 触及1%刻度。 ...

Group 1 - China Iron & Steel Group disclosed plans for its controlling shareholder to increase its stake in the company by 65 million to 130 million yuan [1][2] - A total of 11 A-share listed companies announced share reductions, including Meixin Technology, Southern Precision, and Huasheng Lithium Electric [1][2] Group 2 - Meixin Technology's shareholders plan to reduce their holdings by no more than 3.57% [2] - Southern Precision's shareholders intend to reduce their holdings by no more than 2.54% [2] - Huasheng Lithium Electric's shareholders plan to reduce their holdings by no more than 0.63% [2] - Other companies such as Bo Technology, Hesheng Co., Jiangbolong, and Zhangjiang Hi-Tech also announced share reductions ranging from 0.50% to 3.06% [2]

智通财经APP获悉，香港联交所最新数据显示，11月21日，摩根大通增持药明康德(02359)73.6509万 股，每股作价102.4881港元，总金额约为7548.34万港元。增持后最新持股数目约为2572.02万股，持股 比例为5.03%。 ...

智通财经APP获悉，香港联交所最新数据显示，11月21日，摩根大通增持药明康德(02359)73.6509万 股，每股作价102.4881港元，总金额约为7548.34万港元。增持后最新持股数目约为2572.02万股，持股 比例为5.03%。 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其準確 性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容而產生或 因依賴該等內容而引致之任何損失承擔任何責任。 WUXI APPTEC CO., LTD. * 無錫藥明康德新藥開發股份有限公司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：2359） 海外監管公告 本海外監管公告乃由本公司根據香港聯合交易所有限公司證券上市規則第 13.10B條作出。 茲載列本公司在上海證券交易所網站刊登的以下資料中文全文，僅供參閱。 承董事會命 無錫藥明康德新藥開發股份有限公司 董事長 李革博士 香港，2025年11月26日 截至本公告日期，本公司董事會包括執行董事李革博士、陳民章博士、楊青博士及張朝暉先生； 非執行董事童小幪先生及吳亦兵博士；以及獨立非執行董事盧韶華女士、俞衛博士、張新博士、 詹智玲女士及冷雪松先生。 * 僅供識別 证券代码：603259 证券简称：药明康德 公告编号：临 2025-072 关于股东权益变动触及 1%刻度的提示性公告 相关股东保证向公司提供的信息真实、准确、完整，没有虚假记载、误导性陈 ...